APA (7th ed.) Citation

J, A., K, C., R, W., K, T., A, M., BG, M., . . . K, T. (2026). ESR1 Expression Negatively Correlates with Immune Cell Infiltration and Response to Immune Checkpoint Inhibitors in Estrogen Receptor-Positive/HER2-Negative Breast Cancer. Annals of surgical oncology, 33(1), 758. https://doi.org/10.1245/s10434-025-18260-2

Chicago Style (17th ed.) Citation

J, Arima, et al. "ESR1 Expression Negatively Correlates with Immune Cell Infiltration and Response to Immune Checkpoint Inhibitors in Estrogen Receptor-Positive/HER2-Negative Breast Cancer." Annals of Surgical Oncology 33, no. 1 (2026): 758. https://doi.org/10.1245/s10434-025-18260-2.

MLA (9th ed.) Citation

J, Arima, et al. "ESR1 Expression Negatively Correlates with Immune Cell Infiltration and Response to Immune Checkpoint Inhibitors in Estrogen Receptor-Positive/HER2-Negative Breast Cancer." Annals of Surgical Oncology, vol. 33, no. 1, 2026, p. 758, https://doi.org/10.1245/s10434-025-18260-2.